拢16.7m deal agreed for Manchester MedTech Yourgene
A Manchester-headquartered MedTech company listed on the London Stock Exchange鈥檚 AIM market is set to be acquired for 拢16.7 million. The board of Yourgene has recommended that shareholders accept an offer from Novacyt UK which represents a premium of approximately 167.7% to its closing share price on Friday. Yourgene, which also has bases in Taipei, … Continue reading 拢16.7m deal agreed for Manchester MedTech Yourgene
